Making a statement, Health Minister J P Nadda said from January 1 till February 22, the number of swine flu cases reported by the states stand at 14673.
"The number of deaths for the same period are 841," he said.
The Minister rejected suggestions about shortages of Oseltamivir, drug used for treating Influenza A H1N1 or swine flu, and said it is manufactured in India.
He said the drug, however, cannot be sold over the counter and has to be made available only against prescription and sold through a chemist with license under Schedule X of the Drugs and Cosmetics Act.
"We cannot afford a situation where due to irrational use of the drug, resistance is developed, rendering the drug incapable of fighting the virus. However, to ensure that general public requiring the drug does not face any inconvenience, we have advised the state governments to review the locations of the Schedule X pharmacies and issue fresh licenses for under-represented or not represented locations," he said.
"...To prevent transmission of the disease to the healthcare workers who come in contact with patients, N-95 masks and Personal Protective Equipment are required. We are, on a regular basis, ascertaining from the state governments regarding the stock position...We have already supplied to the affected states 58,000 capsules of Oseltamivir, 3000 N-95 masks and 9500 Personal Protective Equipment," he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
